Express Pharma - Page 904 of 2180 - Express Pharma

Bayer revises access model for Eylea 2mg in India to expand patient eligibility

Leading people in the age of AI

Patent expiries ahead, is India Pharma Inc ready?

Operation Warp Speed to start making COVID-19 vaccine by end of summer, says U.S. official

Cipla receives final approval for generic version of Shire’s Firazyr

Pfizer, BioNTech’s coronavirus vaccine candidates get US FDA’s ‘fast track’ status

Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial

DoP to finalise guidelines to select locations of three bulk drug parks and four med devices parks: Gowda

Institute of Life Sciences, Odisha establishes in vitro cultures of COVID-19

Mumbai, Thane to get 60 per cent of Maharashtra’s remdesivir stock

CDSCO extends consent to import drugs with less than 60 per cent residual shelf life by three months

Glenmark Pharma cuts price of COVID-19 drug by 27 pc to Rs 75/tablet

INST scientists formulate nanoparticle to reduce severity of rheumatoid arthritis